NEW ORLEANS, Feb. 2, 2009 (GLOBE NEWSWIRE) -- Kahn Gauthier Swick, LLC ("KGS") reminds shareholders that February 2, 2008 is the deadline to file lead plaintiff applications in a securities class action lawsuit filed in the United States District Court for the Eastern District of Missouri, on behalf of purchasers of Class A Common Stock, Class B Common Stock, and 7% cumulative convertible Preferred Stock of KV Pharmaceutical Company ("KV" or the "Company") (NYSE:KV-A) (NYSE:KV-B) (NYSE:KVPHP) (CUSIP:482740305) between February 15, 2008 and November 12, 2008, inclusive (the "Class Period").
If you would like to discuss your legal rights, along with the lead plaintiff position and its related responsibilities including overseeing lead counsel with a goal of obtaining a fair settlement, you may e-mail or call KGS Managing Partner Lewis Kahn, without obligation or cost to you, toll free 1-866-467-1400, ext. 100, via cell phone after hours at 504-301-7900, or by e-mail at lewis.kahn@kgscounsel.com.
KV and certain of its officers and directors are charged with violating the Securities Exchange Act of 1934, for issuing a series of materially false statements that concealed and failed to disclose that the Company had published materially inaccurate and false information. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. To learn more about KGS, you may visit www.kgscounsel.com. KGS is a law firm focused on securities class action litigation with offices in New Orleans and New York City.
SPECIAL NOTICE: KGS encourages you to carefully evaluate any firm you may consider to represent your interests in the KV class action. The Private Securities Litigation Reform Act ("PSLRA") permits KV shareholders to choose counsel of their choice to prosecute this action. Critical components of a law firm's ability to successfully prosecute this action and obtain a strong recovery for you include the resources it will dedicate to prosecution of the case, including the number of lawyers the firm has available for the KV action in particular, AND especially the quality of the firm's work. Interested shareholders are encouraged to call for consultation and to request more information about KGS. While KGS has not filed suit yet, the firm is currently conducting its own investigation of KV and invites shareholders to evaluate its complaint when choosing counsel.